MCL coexpression mm9:254

Phase1 CAGE Peaks

	Short description
Mm9::chr10:75400042..75400078,+	p@chr10:75400042..75400078 +
Mm9::chr10:79145051..79145067,+	p6@Cdc34
Mm9::chr11:7097807..7097814,+	p2@Igfbp1
Mm9::chr11:77694689..77694695,-	p@chr11:77694689..77694695 -
Mm9::chr12:105652032..105652072,+	p@chr12:105652032..105652072 +
Mm9::chr12:88504721..88504747,+	p@chr12:88504721..88504747 +
Mm9::chr14:51724838..51724856,+	p@chr14:51724838..51724856 +
Mm9::chr14:52530380..52530414,-	p@chr14:52530380..52530414 -
Mm9::chr15:10288437..10288460,-	p@chr15:10288437..10288460 -
Mm9::chr15:82286766..82286778,+	p@chr15:82286766..82286778 +
Mm9::chr16:22939457..22939468,+	p@chr16:22939457..22939468 +
Mm9::chr17:12586030..12586040,+	p@chr17:12586030..12586040 +
Mm9::chr17:34998096..34998110,-	p@chr17:34998096..34998110 -
Mm9::chr17:56260036..56260043,-	p@chr17:56260036..56260043 -
Mm9::chr17:71439709..71439713,+	p@chr17:71439709..71439713 +
Mm9::chr17:71553871..71553894,+	p7@Lpin2
Mm9::chr18:20828571..20828599,+	p@chr18:20828571..20828599 +
Mm9::chr1:132660649..132660660,-	p@chr1:132660649..132660660 -
Mm9::chr2:32279527..32279549,-	p2@Slc25a25
Mm9::chr2:4848530..4848543,+	p@chr2:4848530..4848543 +
Mm9::chr4:150228125..150228159,+	p4@Errfi1
Mm9::chr4:150228162..150228172,+	p5@Errfi1
Mm9::chr4:150239482..150239517,+	p@chr4:150239482..150239517 +
Mm9::chr4:150240485..150240505,+	p@chr4:150240485..150240505 +
Mm9::chr4:150240916..150240941,+	p@chr4:150240916..150240941 +
Mm9::chr4:150241156..150241181,+	p@chr4:150241156..150241181 +
Mm9::chr5:136206163..136206180,+	p@chr5:136206163..136206180 +
Mm9::chr5:65815567..65815578,-	p@chr5:65815567..65815578 -
Mm9::chr7:147959034..147959049,+	p@chr7:147959034..147959049 +
Mm9::chr8:121966378..121966412,+	p@chr8:121966378..121966412 +
Mm9::chr9:107557382..107557401,-	p@chr9:107557382..107557401 -
Mm9::chr9:46038187..46038279,+	p@chr9:46038187..46038279 +
Mm9::chrX:98571698..98571712,+	p5@Gjb1

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:

---

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

---

Cell Type

Ontology term	p-value	n
metabolising cell	2.42e-08	5
endopolyploid cell	2.42e-08	5
parenchymal cell	2.42e-08	5
polyploid cell	2.42e-08	5
hepatocyte	2.42e-08	5

Uber Anatomy

Ontology term	p-value	n
liver	7.86e-31	22
epithelial sac	7.86e-31	22
digestive gland	7.86e-31	22
epithelium of foregut-midgut junction	7.86e-31	22
anatomical boundary	7.86e-31	22
hepatobiliary system	7.86e-31	22
foregut-midgut junction	7.86e-31	22
hepatic diverticulum	7.86e-31	22
liver primordium	7.86e-31	22
septum transversum	7.86e-31	22
liver bud	7.86e-31	22
digestive tract diverticulum	2.79e-29	23
sac	2.79e-29	23
exocrine gland	1.49e-26	25
exocrine system	1.49e-26	25
abdomen element	5.19e-21	49
abdominal segment element	5.19e-21	49
abdominal segment of trunk	5.19e-21	49
abdomen	5.19e-21	49
subdivision of trunk	8.30e-17	66
mesenchyme	1.11e-15	61
entire embryonic mesenchyme	1.11e-15	61
trunk mesenchyme	3.08e-14	45
trunk region element	5.54e-13	79
epithelial tube	6.28e-12	47
trunk	1.27e-10	90
gut epithelium	1.54e-09	55
endocrine gland	1.75e-09	60
subdivision of digestive tract	7.60e-09	114
digestive system	1.41e-08	116
digestive tract	1.41e-08	116
primitive gut	1.41e-08	116
endo-epithelium	1.51e-08	69
foregut	1.83e-08	80
gland	2.14e-08	65
endoderm-derived structure	2.54e-08	118
endoderm	2.54e-08	118
presumptive endoderm	2.54e-08	118
unilaminar epithelium	3.18e-07	66
endocrine system	3.86e-07	72
immaterial anatomical entity	7.24e-07	79

TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}